OPTIMISE BPH

  • Research type

    Research Study

  • Full title

    OPTIMISE: Optimising Patients’ surgical Treatment Choices in Male Benign Prostatic Hyperplasia (BPH)

  • IRAS ID

    329549

  • Contact name

    Margaret Husted

  • Contact email

    margaret.husted@winchester.ac.uk

  • Sponsor organisation

    University of Winchester

  • Clinicaltrials.gov Identifier

    https://osf.io/378a2/, Open Science Framework Project Registration

  • Duration of Study in the UK

    2 years, 0 months, days

  • Research summary

    Benign Prostatic Hyperplasia (BPH) is a common condition affecting adult males that causes urinary problems and erectile dysfunction. The condition has been shown to have significant impacts on quality of life. Men have often been managing the condition for many years by the time they see a hospital consultant. There are a range of surgical treatments offered across the UK, which vary based on outcome expectancy, level of surgical invasiveness, and side-effects. It is therefore important to ensure men are engaged with the decision-making process for their treatment for BPH, as this is known to influence both patient treatment outcomes and satisfaction. The OPTIMISE project aims to help address this issue. Specifically, this project will address what currently occurs within BPH consultations, how men are making surgical treatment choices for BPH, and what men perceive as a "good improvement" following BPH surgery. The research will be conducted in four urology services in NHS-England. The four sites have been chosen to ensure a breadth of clinical practice, surgical treatment options, and patient perspectives. This research has 3 phases: Phase 1: an observational study (looking at current clinical practice by observing BPH practice and consultations); Phase 2: a sorting task/interview study with BPH patients to see how men weigh up different risks and benefits from surgical options; Phase 3: an interview study with post-surgery BPH patients to understand what they regard as a good improvement. A research schematic (Research Schematic, document attached) has been developed to outline these studies. It is expected that the research will be undertaken within two years and the findings will contribute to the development of a decision aid and/or practice recommendations for use within future BPH surgical consultations.

  • REC name

    London - Chelsea Research Ethics Committee

  • REC reference

    24/PR/0293

  • Date of REC Opinion

    7 May 2024

  • REC opinion

    Further Information Favourable Opinion